Peter Kolchinsky, 10% Owner at Fulcrum Therapeutics, Inc. (FULC), bought 4,089 shares at $5.99 ($24K) on 2022-12-27, disclosed to the SEC on 2022-12-29.
Open-market purchase of $24k FULC by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| VOR | SELL | 2025-10-30 | $20.7M | — | Filing → |
| CDTX | BUY | 2025-06-30 | $100.0M | — | Filing → |
| TYRA | BUY | 2025-06-06 | $23.5M | — | Filing → |